ArticleGland surgery2025
Navigating the rare: a case report of intrathyroidal thymic carcinoma.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Case Report: Definitive radiotherapy for intrathyroidal thymic carcinoma with neuroendocrine differentiation.Frontiers in oncology · 2026Article
- Intrathyroidal thymic carcinoma initially suspected as a parathyroid tumor: a case report and literature review.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intrathyroidal thymic carcinoma (ITTC) is an exceedingly rare malignancy of the thyroid, which presents significant diagnostic challenges. ITTC often has nonspecific clinical manifestations and histological features similar to other thyroid neoplasms, making its diagnosis difficult. This rarity and complexity result in a lack of consensus on its diagnostic criteria and management strategies. ITTC typically arises from ectopic thymic tissue, and despite its malignancy, it generally has a relatively favorable prognosis when accurately diagnosed and treated in a timely manner. Case Description: This case report discusses a rare instance of ITTC in a 38-year-old male patient who presented with a 2-month history of neck lumps, accompanied by symptoms of neck compression and hoarseness. Clinical imaging, including ultrasound, suggested the possibility of lymphoma due to the appearance of a hypoechoic lesion encasing the carotid artery. However, after conducting immunohistochemical analysis, including markers such as CD5 and CD117, a definitive diagnosis of ITTC was made. The case highlights the diagnostic challenges posed by this rare malignancy and the critical role of histopathology in its identification. Conclusions: ITTC is a rare, low-grade malignant tumor that can often be mistaken for other types of thyroid cancers. Multidisciplinary collaboration is essential for accurate diagnosis and optimal treatment planning. While the diagnosis of ITTC can be complex, immunohistochemical markers are instrumental in confirming the presence of this tumor. Despite its rarity, ITTC generally carries a favorable prognosis, with a 5-year survival rate of approximately 90%. This case report contributes to the limited body of literature on ITTC and underscores the importance of recognizing its unique immunophenotype in achieving an accurate diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.